GetTopicDetailResponse(id=601212e9914f, topicName=重度斑禿, introduction=, content=巴瑞替尼 重度斑禿, image=null, comments=0, allHits=126, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sun Jun 22 12:24:36 CST 2025, time=2025-06-22, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=471854, tagList=[TagDto(tagId=471854, tagName=重度斑禿)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2270380, encodeId=7cec22e038020, content=<a href='/topic/show?id=00664830602' target=_blank style='color:#2F92EE;'>#巴瑞替尼#</a> <a href='/topic/show?id=601212e9914f' target=_blank style='color:#2F92EE;'>#重度斑禿#</a>, objectTitle=Am J Clin Dermatol：巴瑞替尼治療重度斑禿長期安全性觀察，長達4年用藥結果及臨床啟示, objectType=article, longId=883603, objectId=8a36883603d6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240819/1724031858573_92910.png, objectUrl=/article/show_article.do?id=8a36883603d6, replyNumber=0, likeNumber=24, createdTime=2025-06-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8a36883603d6, moduleTitle=Am J Clin Dermatol：巴瑞替尼治療重度斑禿長期安全性觀察，長達4年用藥結果及臨床啟示, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8a36883603d6)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-06-22發(fā)表于上海
